Published in AIDS on December 02, 2005
Assessment, diagnosis, and treatment of HIV-associated neurocognitive disorder: a consensus report of the mind exchange program. Clin Infect Dis (2012) 1.31
Anthropometric measures and cognition in middle-aged HIV-infected and uninfected women. The Women's Interagency HIV Study. J Neurovirol (2013) 0.78
Validity of the CogState brief battery: relationship to standardized tests and sensitivity to cognitive impairment in mild traumatic brain injury, schizophrenia, and AIDS dementia complex. Arch Clin Neuropsychol (2009) 2.34
Progressive multifocal leukoencephalopathy and natalizumab--unforeseen consequences. N Engl J Med (2005) 1.85
Delayed fingolimod-associated asystole. Mult Scler (2011) 1.61
Central nervous system immune activation characterizes primary human immunodeficiency virus 1 infection even in participants with minimal cerebrospinal fluid viral burden. J Infect Dis (2011) 1.59
Frequency and phenotype of JC virus-specific CD8+ T lymphocytes in the peripheral blood of patients with progressive multifocal leukoencephalopathy. J Virol (2007) 1.52
High prevalence of multiple human herpesviruses in saliva from human immunodeficiency virus-infected persons in the era of highly active antiretroviral therapy. J Clin Microbiol (2006) 1.34
Neuroimaging correlates of HIV-associated BBB compromise. J Neuroimmunol (2004) 1.27
The HIV Dementia Scale: predictive power in mild dementia and HAART. J Neurol Sci (2007) 1.23
Persistence and pathogenesis of the neurotropic polyomavirus JC. Ann Neurol (2015) 1.21
Inflammatory changes and breakdown of microvascular integrity in early human immunodeficiency virus dementia. J Neurovirol (2004) 1.15
ALS syndrome in patients with HIV-1 infection. J Neurol Sci (2005) 1.14
Stroke in HIV infection and AIDS. Expert Rev Cardiovasc Ther (2009) 1.09
Update on progressive multifocal leukoencephalopathy. Curr Neurol Neurosci Rep (2012) 1.06
Mass lesions of the brain in AIDS: the dilemmas of distinguishing toxoplasmosis from primary CNS lymphoma. AJNR Am J Neuroradiol (2003) 1.02
Progressive multifocal leukoencephalopathy in a patient with Hodgkin lymphoma treated with brentuximab vedotin. Leuk Lymphoma (2012) 1.02
Parkinsonism in hiv-infected patients on highly active antiretroviral therapy. Neurology (2009) 1.00
Isolated Histoplasma capsulatum meningoencephalitis in an immunocompetent child. J Child Neurol (2012) 0.94
Understanding pathogenesis and treatment of HIV dementia: a role for magnetic resonance? Trends Neurosci (2002) 0.94
Progressive multifocal leukoencephalopathy and relapsing-remitting multiple sclerosis: a comparative study. Arch Neurol (2009) 0.93
The bone marrow, B cells, and JC virus. J Neurovirol (2008) 0.93
Considerations on discontinuing natalizumab for the treatment of multiple sclerosis. Ann Neurol (2010) 0.93
Steroids for PML-IRIS: a double-edged sword? Neurology (2009) 0.89
Central Nervous System Infections With Immunomodulatory Therapies. Continuum (Minneap Minn) (2015) 0.87
Low prevalence of varicella zoster virus and herpes simplex virus type 2 in saliva from human immunodeficiency virus-infected persons in the era of highly active antiretroviral therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2010) 0.87
The basis for modeling progressive multifocal leukoencephalopathy pathogenesis. Curr Opin Neurol (2011) 0.86
Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids following influenza vaccination. Arch Pathol Lab Med (2012) 0.86
A placebo-controlled study of memantine for the treatment of human immunodeficiency virus-associated sensory neuropathy. J Neurovirol (2006) 0.86
Wernicke's encephalopathy in the course of chemoradiotherapy for head and neck cancer. Am J Otolaryngol (2010) 0.86
Progressive multifocal leukoencephalopathy in multiple sclerosis. Curr Neurol Neurosci Rep (2013) 0.85
Complications of immunosuppressive/immunomodulatory therapy in neurological diseases. Curr Treat Options Neurol (2012) 0.85
Ziconotide infusion for severe chronic pain: case series of patients with neuropathic pain. Pharmacotherapy (2006) 0.85
Monofocal acute inflammatory Demyelination (MAID): a unique disorder simulating brain neoplasm. South Med J (2002) 0.84
The involvement of astrocytes and kynurenine pathway in Alzheimer's disease. Neurotox Res (2007) 0.84
In vivo replication kinetics of a nef-deleted strain of HIV-1. AIDS (2005) 0.83
JCV-specific CD4 T cell response: another piece of the puzzle in explaining some aspects of AIDS associated PML. AIDS (2003) 0.83
Progressive Multifocal Leukoencephalopathy: Recent Advances and a Neuro-Ophthalmological Review. J Neuroophthalmol (2015) 0.83
Infection risk in patients on multiple sclerosis therapeutics. CNS Drugs (2015) 0.81
Spinal epidural abscess. Curr Infect Dis Rep (2014) 0.81
Substantia nigra depigmentation and exposure to encephalitis lethargica. Ann Neurol (2012) 0.81
Alien hand syndrome. Neurology (2006) 0.81
Disease-modifying drugs for multiple sclerosis and JC virus expression. J Neurovirol (2012) 0.79
Introduction to HIV infection and neuro-AIDS. Handb Clin Neurol (2007) 0.79
The manifold faces of PML and the challenge of diagnosis. Neurology (2011) 0.79
Cervical myelopathy secondary to violent tics of Tourette's syndrome. Neurology (2003) 0.79
The changing landscape of progressive multifocal leukoencephalopathy. Curr Infect Dis Rep (2011) 0.79
Reply to "'Thinking without thinking' about natalizumab and PML". J Neurol Sci (2007) 0.78
Autoimmune markers in HIV-associated dementia. J Neuroimmunol (2003) 0.78
Too much of a good thing? IRIS with natalizumab-associated PML. Neurology (2011) 0.77
HIV and the central nervous system. Compr Ther (2002) 0.77
Primary lateral sclerosis with HIV-1 infection. Neurology (2008) 0.77
Axonal excitability in viral polyneuropathy and nucleoside neuropathy in HIV patients. J Neurol Neurosurg Psychiatry (2010) 0.77
Genetic testing and HIV dementia: teasing out the molecular mechanisms of disease. AIDS (2010) 0.76
Identification of potential antibody markers in HIV-associated dementia. J Neuroimmunol (2004) 0.76
Memory and the mammillothalamic tract. AJNR Am J Neuroradiol (2004) 0.75
Multiple sclerosis remission following antiretroviral therapy in an HIV-infected man. J Neurovirol (2014) 0.75
Is the presence of antibodies in CSF sufficient to make a definitive diagnosis of Lyme disease? Neurology (2007) 0.75
Parinaud syndrome heralding MS. Neurology (2003) 0.75
Infectious myelopathies. Continuum (Minneap Minn) (2011) 0.75
Acute central cord syndrome with bodybuilder sign. Clin Neurol Neurosurg (2007) 0.75
The interface of infectious disease and neuro-ophthalmology. J Neuroophthalmol (2012) 0.75
Hereditary hemorrhagic telangectasia and spinal cord infarct: case report with a review of the neurological complications of HHT. Clin Neurol Neurosurg (2008) 0.75
Neuro-AIDS in the developing world. Neurology (2012) 0.75
Iatrogenic fungal infections of central nervous system. Curr Neurol Neurosci Rep (2013) 0.75
A giant MS plaque mimicking PML during natalizumab treatment. J Neurol Sci (2010) 0.75
Other opportunistic infections of the central nervous system in AIDS. Handb Clin Neurol (2007) 0.75
Presumptive human herpesvirus 6 myelopathy in an immunocompetent patient. J Neurovirol (2014) 0.75
Against all odds: surviving rhino-orbital-cerebral mucormycosis: a case report. J Neurovirol (2012) 0.75
Homonymous hemianopsia complicating treatment of postoperative epistaxis. Neurology (2006) 0.75
Progressive multifocal leukoencephalopathy. Handb Clin Neurol (2007) 0.75
Proceedings of the 10th International Conference on Neuroscience of HIV Infection: emerging issues. J Neurovirol (2002) 0.75
Volitional opsoclonus. Neurology (2005) 0.75